D. Peston

发表

Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis

R. Wait, K. Lundberg, A. Kinloch, 2005, Arthritis research & therapy.

An unusual triple‐negative breast carcinoma

S. Shousha, C. Palmieri, O. Gojis, 2009, Histopathology.

Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virus

T. Powles, A. Sandison, B. Gazzard, 2004, The Journal of Laryngology & Otology.

Immunohistochemical demonstration of oestrogen and progesterone receptors in paraffin sections of breast carcinoma

S. Shousha, D. Peston, 1997 .

Provocation of experimental aortic inflammation and dilatation by inflammatory mediators and Chlamydia pneumoniae

J. Powell, I. Franklin, D. Peston, 2001, The British journal of surgery.

Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma.

S. Shousha, D. Peston, A. Zidan, 1997, Journal of clinical pathology.

Role of Helicobacter pylori Infection in Complications from Meckel's Diverticulum

Z. Ackerman, P. Cohen, D. Peston, 2003, Digestive Diseases and Sciences.

FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer.

J. Saklatvala, T. Vincent, J Saklatvala, 2007, Osteoarthritis and cartilage.

FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer.

J. Hartman, E. Lam, S. Shousha, 2009, International journal of oncology.

p57KIP2 immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy

N. Sebire, H. Rees, M. Seckl, 2004, Histopathology.

Phosphorylation of Estrogen Receptor-α at Ser167 Is Indicative of Longer Disease-Free and Overall Survival in Breast Cancer Patients

Simak Ali, S. Shousha, R. Coombes, 2007, Clinical Cancer Research.

Differential expression of p53 and p504s in hyperplastic polyp, sessile serrated adenoma and traditional serrated adenoma

N. Ngo, P. Cohen, P. Tekkis, 2010, International Journal of Colorectal Disease.

Primary Glial Tumor of the Retina With Features of Myxopapillary Ependymoma

J. Moss, F. Roncaroli, J. Olver, 2005, The American journal of surgical pathology.

Immunocytochemical analysis of AE1/AE3, CK 14, Ki-67 and p53 expression in benign, premalignant and malignant oral tissue to establish putative markers for progression of oral carcinoma

A. Sandison, O. Murayama, D. Peston, 2004, British journal of biomedical science.

CD10 immunostaining of bile canaliculi in liver biopsies: change of staining pattern with the development of cirrhosis

S. Shousha, I. Murray-Lyon, D. Bansi, 2004, Histopathology.

Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial.

Simak Ali, S. Shousha, D. Vigushin, 2005, The Lancet. Oncology.

Evaluation of automated silver‐enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens

S. Shousha, B. Jasani, D. Peston, 2009, Histopathology.

Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study.

S. Shousha, B. Vonderhaar, D. Peston, 2001, Journal of clinical pathology.

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.

S. Shousha, P. Hall, D. Barnes, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Epidermal growth factor receptor status in early stage breast cancer is associated with cellular proliferation but not cross-talk

S. Shousha, J. Krell, Richard Szydlo, 2011, Journal of Clinical Pathology.

Phosphorylation of ERa at serine 118 in primary breast cancer and in tamoxifen- resistant tumours is indicative of a complex role for ERa phosphorylation in breast cancer progression

S. Shousha, S. Ali, H. Sinnett, 2006 .

Triple Negative, Basal Cell Type and EGFR Positive Invasive Breast Carcinoma in Kuwaiti and British Patients

S. Shousha, I. Francis, E. Ayad, 2009, The Breast Journal.

Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression.

S. Shousha, R. Coombes, R. Nicholson, 2006, Endocrine-related cancer.

Comparison of immunoperoxidase staining of 3 different types of CD5 antibodies in a spectrum of breast lesions.

S. Shousha, D. Peston, R. Walsh, 2001, Archives of Pathology & Laboratory Medicine.

CD9 immunohistochemical staining of breast carcinoma: unlikely to provide useful prognostic information for routine use *

S. Shousha, D. Peston, F. Jamil, 2001, Histopathology.

Revisiting the past: utilizing archival tissue for the detection and quantification of gene expression

C. Bunker, S. Kaye, D. Peston, 2009, The British journal of dermatology.

Abstract

H. Sinnett, J. Gee, D. Peston, 2006, Breast Cancer Research and Treatment.

Human endogenous retrovirus K (HERV‐K) rec mRNA is expressed in primary melanoma but not in benign naevi or normal skin

C. Bunker, M. Gore, M. Mcclure, 2013, Pigment cell & melanoma research.

FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer.

J. Hartman, E. Lam, S. Shousha, 2009, International journal of oncology.